WHO Says Indian Company Mishandles Clinical Trial Records

Jul 08, 2015

Wall Street Journal

According to a Wall Street Journal article, a CRO in India is being scolded for its handling of clinical trial records.

Quest Life Sciences was issued a notice of concern by the World Health Organization after an inspection last October of a facility in Chennai, India. The agency was reviewing work involving a clinical study of AIDS drugs, but the problems were big enough that the WHO recommended rejecting the study, the notice said.

The article went on to say when the WHO inspectors arrived, Quest employees were still filling out forms for the study. And as inspectors entered the room, the Quest staff attempted to hide some of those documents, according to the notice. The WHO staffers later determined that some of the paperwork was actually backdated.

Read the full WSJ article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments